Michael Siebels
Impact in
- Cancer Research top 1%
- Cancer Genomics and Diagnostics
- Cancer, Hypoxia, and Metabolism
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
Papers in ⓘ
-
- Renal cell carcinoma treatment 28
-
- Renal and related cancers 18
- Co-authors
- Sylvie Négrier (3 shared papers)Tomasz Demkow (1 shared paper)Sara M. Freeman (1 shared paper)Cezary Szczylik (1 shared paper)E Solska (1 shared paper)Thomas E. Hutson (1 shared paper)Apurva A. Desai (1 shared paper)Bernard Escudier (1 shared paper)
- Journals
- World Journal of Urology (5 papers)Journal of Clinical Oncology (4 papers)British Journal of Urology (4 papers)The Journal of Urology (3 papers)Nephrology Dialysis Transplantation (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Siebels
61 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Cancer Research 1.6k
- Pulmonary and Respiratory Medicine 3.4k
- Oncology 1.6k
- Molecular Biology 2.7k
- Urology 230
Countries citing papers authored by Michael Siebels
This map shows the geographic impact of Michael Siebels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Siebels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Siebels more than expected).
Fields of papers citing papers by Michael Siebels
This network shows the impact of papers produced by Michael Siebels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Siebels. The network helps show where Michael Siebels may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Siebels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 3804 |
| 2 | 2005 | 193 | |
| 3 | 2004 | 154 | |
| 4 | 2002 | 93 | |
| 5 | 2010 | 92 | |
| 6 | 2010 | 85 | |
| 7 | 2005 | 74 | |
| 8 | 2005 | 59 | |
| 9 | 2001 | 46 | |
| 10 | 2003 | 44 | |
| 11 | 2002 | 38 | |
| 12 | 2000 | 35 | |
| 13 | 2010 | 30 | |
| 14 | 2006 | 30 | |
| 15 | 2009 | 29 | |
| 16 | 2005 | 29 | |
| 17 | 2005 | 28 | |
| 18 | 1993 | 27 | |
| 19 | 2005 | 26 | |
| 20 | 2001 | 23 |
About Michael Siebels
Michael Siebels is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Oncology and Cancer Research, having authored 65 papers that have together received 5.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (28 papers), Renal and related cancers (18 papers), Bladder and Urothelial Cancer Treatments (13 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Genomics and Diagnostics (9 papers), Immunotherapy and Immune Responses (6 papers), Urinary Bladder and Prostate Research (5 papers) and Nanoplatforms for cancer theranostics (4 papers). The work is most often cited by research in Cancer Research (1.6k citations), Pulmonary and Respiratory Medicine (3.4k citations), Oncology (1.6k citations), Molecular Biology (2.7k citations) and Urology (230 citations). Michael Siebels has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Sylvie Négrier, Tomasz Demkow, Sara M. Freeman, Cezary Szczylik, E Solska, Thomas E. Hutson, Apurva A. Desai, Bernard Escudier, Minghua Shan and Stéphane Oudard. Their work appears in journals such as World Journal of Urology, Journal of Clinical Oncology, British Journal of Urology, The Journal of Urology and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.